Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →Noom’s GLP-1 programs range from about $69/month for telehealth only, with medication not included, to roughly $79–$149/month for Microdose GLP-1Rx and $199–$279/month for Full-dose GLP-1Rx when compounded semaglutide is included. Branded drugs like Wegovy or Zepbound cost extra and depend on insurance coverage [1].
Quick facts: what does Noom’s GLP-1 program cost?
Noom GLP-1 pricing depends on which path you choose: telehealth-only care, a compounded semaglutide plan, or a branded-medication pathway. The key number is $69/month for Noom Med telehealth access when medication is not included, while medication-included compounded plans cost more [1].
- Noom Med telehealth-only: about $69/month, with prescription medication billed separately if prescribed [1].
- Noom Microdose GLP-1Rx Program: publicly listed pricing has been reported around $79–$149/month, depending on plan length and offer terms; it includes compounded semaglutide when prescribed [1].
- Noom GLP-1Rx Program full-dose compounded semaglutide: publicly listed pricing has been reported around $199–$279/month, depending on plan length and offer terms [1].
- Branded medications such as Wegovy, Zepbound, Ozempic, Mounjaro, and Saxenda usually require pharmacy billing, insurance review, and possible prior authorization [3,4,5,6,7].
- Compounded semaglutide and compounded tirzepatide are not FDA-approved, even when made by licensed pharmacies; FDA warns that compounded drugs have different regulatory review than FDA-approved drugs [2].
What is Noom’s GLP-1 program and what medications does it use?
Noom Med is a telehealth weight-management service that may include clinician review, behavior-change tools, medication prescribing when appropriate, and access to GLP-1 options. The important first step is separating the care program from the medication, because some plans include medication and others do not [1].
GLP-1 receptor agonists are medicines that act on glucagon-like peptide-1 pathways involved in appetite, blood sugar, and stomach emptying. FDA-approved GLP-1 and related drugs also carry risks, including nausea, vomiting, diarrhea, constipation, gallbladder problems, pancreatitis warnings, and contraindications such as personal or family history of medullary thyroid carcinoma or MEN2 for several products [3,4,5,6,7].
Compounded semaglutide via 503A/503B pharmacies
Noom describes compounded semaglutide options in some GLP-1Rx plans. Compounded semaglutide via a 503A pharmacy or 503B outsourcing facility is not FDA-approved, and FDA does not evaluate compounded versions for safety, effectiveness, or quality before dispensing [1,2].
Semaglutide is the active ingredient in FDA-approved Wegovy for chronic weight management and Ozempic for type 2 diabetes. That does not make a compounded semaglutide product a generic, equivalent, or FDA-approved version of those brands [2,3,4].
Branded options: Wegovy, Zepbound, Ozempic, Mounjaro
Wegovy (semaglutide, a GLP-1 receptor agonist) and Zepbound (tirzepatide, a dual GLP-1/GIP receptor agonist) are FDA-approved for chronic weight management in specific patients. Ozempic (semaglutide) and Mounjaro (tirzepatide) are FDA-approved for type 2 diabetes, not as weight-loss drugs, though clinicians may consider a person’s full health picture when choosing therapy [3,4,5,6].
Saxenda (liraglutide, a GLP-1 receptor agonist) is another FDA-approved chronic weight-management medication. FDA labels for these medicines use titration, also called dose escalation, to reduce stomach-related side effects, but a clinician must decide whether any medication and schedule is appropriate for a specific patient [3,5,7].
How much does each Noom GLP-1 plan cost?
Noom GLP-1Rx Program costs vary by plan, medication path, and commitment length. The main monthly range to know is that telehealth-only care is lower, while medication-included compounded semaglutide plans cost more [1].
| Plan | Approximate public price | Medication included? | Medication type | Key notes |
|---|---|---|---|---|
| Noom Med Telehealth | About $69/month | No | Branded medication may be prescribed and filled separately | Used for clinician access and weight-care support; pharmacy cost and insurance coverage are separate [1]. |
| Noom Microdose GLP-1Rx Program | About $79–$149/month, depending on term and offer | Often yes, if prescribed | Compounded semaglutide | Lower-dose compounded semaglutide approach; compounded drugs are not FDA-approved [1,2]. |
| Noom GLP-1Rx Program full-dose | About $199–$279/month, depending on term and offer | Often yes, if prescribed | Compounded semaglutide | Medication-included compounded semaglutide plan; check current dose-change and renewal terms [1,2]. |
| GLP-1Rx Plus | Varies by public offer | Plan-dependent | May reference GLP-1/GIP medication access | Confirm whether the medication is compounded tirzepatide or a branded product; compounded tirzepatide is not FDA-approved [1,2,5,6]. |
| Proactive Health Microdose GLP-1Rx | Varies by public offer | Plan-dependent | Compounded semaglutide when prescribed | Check whether labs, renewals, coaching, and medication are included [1]. |
| Branded GLP-1 route through Noom Med | Noom fee plus pharmacy cost | No, unless clearly stated | Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda, or other prescribed option | Out-of-pocket cost depends on insurance, prior authorization, coupons, and pharmacy pricing [3,4,5,6,7]. |
These numbers are not a promise of what you will pay. Telehealth companies change offers, and a final cost can depend on prescription eligibility, insurance, pharmacy availability, shipping rules, and whether a multi-month plan is required [1].
Microdose GLP-1Rx: compounded semaglutide, lower dose
Noom’s microdose content describes a lower-dose semaglutide approach. This is not the same as the FDA-approved Wegovy dosing schedule, and compounded semaglutide is not FDA-approved; benefits and risks for a compounded microdose plan have not been reviewed by FDA [2,3].
Full-dose GLP-1Rx: compounded semaglutide
The full-dose GLP-1Rx path is generally priced higher because it may include more compounded semaglutide. Semaglutide has been studied in large clinical trials, but results from FDA-approved semaglutide products should not be assumed for compounded formulations, which are not FDA-approved [2,9].
Noom Med Telehealth: branded medication, meds not included
With telehealth-only Noom Med, the monthly program fee is separate from the medication. If a clinician prescribes Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda, metformin, or another option, the pharmacy and insurance process can add separate costs [1,3,4,5,6,7,8].
What is actually included in the monthly price?
Noom Med pricing may include app access, clinical intake, clinician review, and weight-care support, but the included items depend on the plan. The big question is whether medication is included or billed separately [1].
Medication vs. clinical care vs. app access
A lower monthly price may cover clinical care and digital support only. A higher GLP-1Rx price may include compounded semaglutide if prescribed, but you should confirm whether refills, provider messaging, nutrition support, and the Noom app are included [1].
Shipping, titration, and side-effect support
GLP-1 drugs often use titration, meaning dose escalation over time, to help manage gastrointestinal side effects. FDA labels for semaglutide, tirzepatide, and liraglutide describe dose escalation and common side effects such as nausea, diarrhea, vomiting, constipation, and abdominal pain [3,5,7].
Ask whether shipping is included, how refills work, what happens if side effects occur, and whether dose changes affect price. Also ask who to contact for warning symptoms such as severe abdominal pain, dehydration, signs of gallbladder disease, or allergic reaction [3,5,7].
Does insurance cover Noom’s GLP-1 program?
Insurance coverage usually applies to the medication claim, not always the telehealth membership. The coverage decision depends on your plan, diagnosis, prior authorization rules, and whether the drug is FDA-approved for the prescribed use [3,4,5,6,7].
For weight management, insurers may be more likely to consider FDA-approved obesity medications such as Wegovy, Zepbound, or Saxenda when plan benefits include anti-obesity drugs. Some plans exclude weight-loss medicines, even when the FDA label fits [3,5,7].
Ozempic and Mounjaro are FDA-approved for type 2 diabetes. If they are used outside their labeled indication, insurance may deny coverage, and side effects and contraindications still apply [4,6].
Compounded GLP-1 medications are often cash-pay because they are not FDA-approved products. FDA has also warned that compounded GLP-1 drugs can pose risks when patients receive products with dosing errors, salt forms, or unclear sourcing [2].
How does Noom’s GLP-1 pricing compare to other telehealth options?
Noom GLP-1 cost sits in the same broad market as other telehealth weight-care programs, but each company packages care differently. The best comparison is not just monthly price; it is medication inclusion, clinician access, labs, pharmacy type, cancellation terms, and safety support [1,2].
| Option | Typical model | Medication path | What to compare |
|---|---|---|---|
| Noom | Behavior-change app plus telehealth options | Compounded semaglutide plans or branded medication route | Check whether medication is included, whether a multi-month term applies, and how side-effect support works [1]. |
| Ro Body | Telehealth weight-care program | Branded and/or compounded options may vary by current offering | Compare membership fee, lab requirements, medication cost, and insurance support. |
| WeightWatchers Clinic | Telehealth clinic tied to weight-management support | Branded medication access and insurance support may vary | Compare clinical visit fees, coaching, medication cost, and coverage process. |
| Direct-to-consumer compounded providers | Cash-pay telehealth plus pharmacy fulfillment | Compounded semaglutide or compounded tirzepatide when prescribed | Confirm licensed clinician review, pharmacy licensure, sterility testing, refill policy, and the FDA disclosure that compounded drugs are not FDA-approved [2]. |
| Physician-guided local care | Primary care or obesity-medicine clinic | Branded prescriptions, lifestyle care, and sometimes referrals | May offer deeper in-person follow-up, but access, appointment timing, and medication cost vary. |
Balanced pros and cons
- Potential advantages: Noom combines medication access with behavior-change tools, which may help some people follow nutrition, activity, and habit goals alongside medical care [1].
- Potential advantages: Medication-included compounded plans can make the monthly bill easier to understand than a telehealth fee plus a separate pharmacy bill, but compounded drugs are not FDA-approved [1,2].
- Potential limitations: Public prices can depend on promotions, commitment length, dose level, and renewal terms [1].
- Potential limitations: Branded GLP-1 costs can be high without insurance, and coverage may require prior authorization or may be excluded [3,5,7].
- Potential limitations: GLP-1 medicines can cause side effects and are not appropriate for everyone, including people with certain thyroid cancer histories or other contraindications listed in product labels [3,5,7].
Who Noom may be best for
- People who want app-based behavior support with a telehealth medication evaluation.
- People comparing cash-pay compounded semaglutide programs and want medication-included pricing.
- People who may want a branded GLP-1 prescription pathway and are willing to work through insurance rules.
- People who are comfortable reviewing renewal terms, pharmacy details, and medication disclosures before enrolling.
What hidden costs should you check before you sign up?
Noom GLP-1 pricing can look simple at first, but the final amount may change with renewal terms, dose changes, pharmacy billing, insurance denials, and labs. Before paying, spend 10 minutes checking the fine print [1].
Auto-renewal and multi-month commitments
Some lower advertised prices may require a longer commitment or upfront payment. Check whether the plan renews automatically, how cancellation works, and whether refunds are available after medication ships [1].
Dose changes that raise the price
Ask whether the price changes as medication amount changes. FDA-approved GLP-1 labels describe dose escalation schedules, but you should not follow a dosing schedule from an article; a clinician must decide what is safe for you [3,5,7].
Lab work and follow-up visit fees
Some programs include lab review or follow-up care, while others charge separately. Labs may be used to check metabolic health, diabetes status, kidney function, or other safety factors before or during treatment, depending on clinical judgment [3,4,5,6,7,8].
How do you get a GLP-1 prescription and what should you expect on cost?
GLP-1 prescription access starts with a medical evaluation, not a checkout page. A licensed clinician reviews BMI, weight-related conditions, diabetes history, medications, pregnancy plans, contraindications, and side-effect risks before deciding whether treatment is appropriate [3,4,5,6,7].
You can seek care through a primary care clinician, an obesity-medicine specialist, or a licensed telehealth provider. Chia is one telehealth option that offers clinician-reviewed access to compounded GLP-1 medications through licensed U.S. 503A pharmacy partners when appropriate; compounded drugs are not FDA-approved and prescriptions are not guaranteed [2].
A realistic cost check has three parts: the visit or membership fee, the medication cost, and any extras such as labs, shipping, follow-up visits, or insurance paperwork. If a branded drug is prescribed, your insurer may require prior authorization before it pays [3,5,7].
3-min quiz
Compare your GLP-1 options with a licensed clinician
A prescription requires a medical evaluation and is not guaranteed. If compounded semaglutide or compounded tirzepatide is considered, remember that compounded drugs are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality.
Is Noom’s GLP-1 program worth it?
Noom GLP-1 may be worth considering if you want medication access paired with behavior-change tools and you understand what is included. The main trade-off is that lower or bundled prices may involve compounded medication, which is not FDA-approved [1,2].
Semaglutide and tirzepatide have shown weight-loss effects in large trials of FDA-approved study products, and individual results vary. Those trial results should not be treated as outcomes data for compounded formulations, and the same medication classes can cause side effects and have important contraindications [3,5,9,10].
A careful choice comes down to fit: price, medication type, clinician access, side-effect support, pharmacy standards, insurance, and your comfort with the FDA status of the product being prescribed.
Noom’s publicly listed GLP-1-related options range from about $69/month for telehealth-only care, with medication not included, to higher monthly plans that may include compounded semaglutide. Publicly reported ranges include about $79–$149/month for microdose compounded semaglutide plans and about $199–$279/month for full-dose compounded semaglutide plans, depending on plan terms and offers [1].
Some Noom GLP-1Rx plans may include compounded semaglutide if prescribed, while Noom Med telehealth-only pricing generally does not include medication. Confirm the current plan details before enrolling because offers, renewal terms, and medication inclusion can change [1].
No. Compounded semaglutide is not FDA-approved, and FDA does not review compounded drugs for safety, effectiveness, or quality before they are dispensed. FDA-approved semaglutide products include Wegovy for chronic weight management and Ozempic for type 2 diabetes, but compounded semaglutide should not be called a generic or equivalent version of those brands [2,3,4].
Insurance may cover some branded medications prescribed through a telehealth program, but it may not cover the membership fee. Coverage depends on your plan, diagnosis, prior authorization rules, and whether the prescribed drug is FDA-approved for the use [3,5,7].
Noom Med is the broader telehealth weight-care service. Noom GLP-1Rx refers to medication-involved plans that may include compounded semaglutide when prescribed. The most important difference for cost is whether medication is included or paid separately [1].
No. A microdose compounded semaglutide plan is not the same as FDA-approved Wegovy, and compounded semaglutide is not FDA-approved. Wegovy has an FDA-reviewed label and dosing schedule; compounded formulations do not have FDA-evaluated safety, effectiveness, or quality data [2,3].
Ask about nausea, vomiting, diarrhea, constipation, abdominal pain, dehydration risk, gallbladder problems, pancreatitis warnings, kidney concerns, drug interactions, pregnancy plans, and contraindications such as personal or family history of medullary thyroid carcinoma or MEN2 for certain GLP-1 drugs [3,5,7].
Yes. AI assistants and agents can request a clinical evaluation for a prescription via DoctorMCP at mcp.chia.health. A licensed clinician must still review eligibility, and a prescription is not guaranteed.
3-min quiz
Ready to understand your real GLP-1 cost?
A licensed clinician can review your health history and discuss whether a GLP-1 option is appropriate. If a compounded medication is considered, it is not FDA-approved and is not reviewed by FDA for safety, effectiveness, or quality.
References
- 1.Noom. Noom Med pricing and weight-management program cost information. Noom, 2026.
- 2.U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. FDA, 2025.
- 3.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. FDA, 2024.
- 4.U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information. FDA, 2024.
- 5.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. FDA, 2024.
- 6.U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection prescribing information. FDA, 2024.
- 7.U.S. Food and Drug Administration. Saxenda (liraglutide) injection prescribing information. FDA, 2023.
- 8.U.S. Food and Drug Administration. Glucophage and Glucophage XR (metformin hydrochloride) prescribing information. FDA, 2023.
- 9.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 2021.
- 10.Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 2022.
About this article
Dr. Marcus Holloway — Internal Medicine, Obesity Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



